This inventor holds 4 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Sato Pharmaceutical Co., Ltd.. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Eri Kondoh: Innovator in Pharmaceutical Chemistry
Introduction
Eri Kondoh is a notable inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of four patents to her name, her work focuses on innovative solutions for health-related issues.
Latest Patents
One of Eri Kondoh's latest patents is centered around a difluoromethylene compound. This compound exhibits URAT1 inhibitory activity, which is crucial for developing a blood uric acid level-reducing agent. The patent details a pharmaceutical composition that includes this compound, represented by a specific formula. This innovation has the potential to impact treatments for conditions related to elevated uric acid levels.
Career Highlights
Eri Kondoh has established herself as a key figure in her field through her work at Sato Pharmaceutical Co., Ltd. Her research and inventions have contributed to advancements in pharmaceutical formulations and therapeutic agents. Her dedication to innovation is evident in her patent portfolio, which reflects her commitment to improving health outcomes.
Collaborations
Eri has collaborated with notable colleagues, including Keita Nagai and Koh Nagasawa. These partnerships have fostered a collaborative environment that enhances the research and development process within her company.
Conclusion
Eri Kondoh's contributions to pharmaceutical chemistry through her innovative patents demonstrate her expertise and commitment to advancing medical science. Her work continues to pave the way for new therapeutic options in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile